IMPLICATIONS OF ULTRASONICALLY DIAGNOSED POLYCYSTIC OVARIES .1. CORRELATIONS WITH BASAL HORMONAL PROFILES

被引：51

作者：

GADIR, AA

KHATIM, MS

MOWAFI, RS

ALNASER, HMI

MUHARIB, NS

SHAW, RW

机构：

[1] Academic Department of Obstetrics and Gynaecology, Royal Free Hospital, NW3 2QG, London, Pond Street

[2] Department of Biochemistry, Faculty of Medicine, Kuwait University, Safat 13110

[3] Maternity Hospital, Safat

[4] Endocrinology Department, Sabah Hospital, Kuwait

[5] Academic Department of Obstetrics and Gynaecology, Royal Free Hospital, NW3 2QG, London, Pond Street

来源：

HUMAN REPRODUCTION | 1992年 / 7卷 / 04期

关键词：

POLYCYSTIC OVARIES; POLYCYSTIC OVARIAN DISEASE; ENDOCRINOPATHY; MENSTRUAL DYSFUNCTION; HIRSUTISM;

D O I：

10.1093/oxfordjournals.humrep.a137668

中图分类号：

R71 [妇产科学];

学科分类号：

100211 ;

摘要：

The incidence of ultrasonically diagnosed polycystic ovaries (PCO) was studied in 389 Arab patients with different types of menstrual dysfunction and 100 normal women with regular menstruation. Two-hundred-and-forty-six patients (63.2%) were found to have PCO but only 206 (53.0%) were confirmed as cases of polycystic ovarian disease (PCOD) on endocrine grounds. Polycystic ovaries were diagnosed in 50% of patients with hyperprolactinaemia, 36.4% with hypothyroidism, 23.7% with hypothalamic dysfunction, 100% with adrenal 21-hydroxylase deficiency and in 16.0% of normal women. More women with PCOD presented with oligomenorrhoea or dysfunctional uterine bleeding (77.7%) and hirsutism (72.3%) but obesity had no discriminating value between the groups with different diagnoses. Ultrasonic diagnosis of PCO should be supplemented with an endocrine biochemical assessment to prevent overdiagnosis of PCOD and to exclude other endocrine dysfunctions.

引用

页码：453 / 457

页数：5

共 14 条

[1] Abdel Gadir A., Khatim M.S., Mowafi R.S., Alnaser H., Alzaid H., Shaw R.W., Hormonal changes in patients with polycystic ovarian disease after ovarian electrocautery or pituitary desensitization, Clin, Endocrinol, 32, pp. 749-754, (1990)
[2] Abdel Gadir A., Mowafi R.S., Alnaser Airasaid H.A.H., Alonezi O.M., Shaw R.W., Ovarian electrocautery versus human menopausal gonadotrophins and pure follicle stimulating hormone therapy in the treatment of patients with polycystic ovarian disease, Clin, Endocrinol, 33, pp. 585-592, (1990)
[3] Abdel Gadir A., Khatim M.S., Mowafi R.S., Alnaser H., Alzaid H., Shaw R.W., Polycyclic ovaries: Do these represent a specific endocrinopathy, Br, J, Obstet, Gynaecol, 98, pp. 300-305, (1991)
[4] Adams J., Poison D.W., Franks S., Prevalence of polycystic ovaries in women with anovulation and idiopathic hirsutism, Br, Med, J, 293, pp. 355-359, (1986)
[5] Campbell S., Goessens L., Goswamy R., Whitehead M., Real time ultrasonography for determination of ovarian morphology and volume, A possible early screening test for ovarian cancer?, Lancet, 1, pp. 425-426, (1982)
[6] Conway G.S., Honour J.W., Jacobs H.S., Heterogeneity of polycystic ovary syndrome: Oinical, endocrine and ultrasound features in 556 patients, Clin, Endocrinol, 30, pp. 459-470, (1989)
[7] Fenriman D., Gallwey J.D., Oinical assessment of body hair growth in women, Clin, Endocrinol, 21, pp. 1340-1447, (1961)
[8] Fisher E.R., Gregorio R., Stephan T., Nolan S., Danowski T.S., Ovarian changes in women with morbid obesity, Obstet, Gynecol, 44, pp. 839-844, (1974)
[9] Glass A.R., Burman K.D., Dahms W.T., Boehm T.M., Endocrine Function in Human Obesity, Metabolism, 30, pp. 89-104, (1981)
[10] Goldzieher J.W., Green J.A., The polycystic ovary: Clinical and histological features, J, Clin, Endocrinol, Metab, 22, pp. 325-338, (1962)

← 1 2 →